Stage IIIB Breast Cancer AJCC v7 Suspended Phase 2 Trials for Atezolizumab (DB11595)

IndicationStatusPhase
DBCOND0092287 (Stage IIIB Breast Cancer AJCC v7)Suspended2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02883062Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast CancerTreatment